Overview Dividends

(BBWI) Bath & Body Works - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0708301041

Fragrance, Candles, Soap, Lotion, Sanitizer

EPS (Earnings per Share)

EPS CAGR: -45.52%
EPS Trend: -22.1%

Last SUE: -1.68σ
Qual. Beats: 0

Revenue

Revenue CAGR: -19.44%
Revenue Trend: -21.5%

Last SUE: -1.32σ
Qual. Beats: 0

Risk via 10d forecast
Volatility	98.2%
Value at Risk 5%th	149%
Relative Tail Risk	-7.66%

Reward TTM
Sharpe Ratio	-0.95
Alpha	-67.08

Character TTM
Hurst Exponent	0.570
Beta	1.543
Beta Downside	1.641

Drawdowns 3y
Max DD	69.98%
Mean DD	26.73%
Median DD	27.28%

Description: BBWI Bath & Body Works November 06, 2025

Bath & Body Works, Inc. (NYSE: BBWI) is a specialty retailer focused on home fragrance, personal care, and related products, offering items such as 3-wick candles, diffusers, hand soaps, lotions, and body creams under the Bath & Body Works, White Barn, and other brand names.

The company sells its merchandise through a network of over 1,800 retail stores and a growing e-commerce platform in the United States and Canada, while international expansion is pursued via franchise, licensing, and wholesale partnerships.

Key recent metrics: FY 2023 revenue was approximately $3.5 billion, with same-store sales (SSS) up 4.2% YoY and e-commerce sales accelerating to roughly 15% of total revenue, reflecting strong digital adoption. The sector is highly sensitive to consumer discretionary spending and inflation trends, making household disposable income and CPI movements critical drivers of BBWI’s top-line performance.

For a deeper, data-driven dive into BBWI’s valuation assumptions and scenario analysis, you may find the research tools on ValueRay useful.

BBWI Stock Overview

Market Cap in USD	3,040m
Sub-Industry	Other Specialty Retail
IPO / Inception	1985-07-01
Return 12m vs S&P 500	-61.6%
Analyst Rating	3.85 of 5

BBWI Dividends

Metric	Value
Dividend Yield	5.39%
Yield on Cost 5y	3.59%
Yield CAGR 5y	27.79%
Payout Consistency	82.7%
Payout Ratio	21.1%

BBWI Growth Ratios

Metric	Value
CAGR 3y	-26.56%
CAGR/Max DD Calmar Ratio	-0.38
CAGR/Mean DD Pain Ratio	-0.99
Current Volume	27383.5k
Average Volume	6035.8k

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (699.0m TTM) > 0 and > 6% of Revenue (6% = 441.2m TTM)

FCFTA 0.19 (>2.0%) and ΔFCFTA 6.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 4.46% (prev 1.95%; Δ 2.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.24 (>3.0%) and CFO 1.18b > Net Income 699.0m (YES >=105%, WARN >=100%)

Net Debt (4.74b) to EBITDA (1.49b) ratio: 3.18 <= 3.0 (WARN <= 3.5)

Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (211.6m) change vs 12m ago -3.37% (target <= -2.0% for YES)

Gross Margin 44.13% (prev 43.97%; Δ 0.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 147.5% (prev 149.1%; Δ -1.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.34 (EBITDA TTM 1.49b / Interest Expense TTM 283.0m) >= 6 (WARN >= 3)

Altman Z'' 0.69

(A) 0.07 = (Total Current Assets 1.88b - Total Current Liabilities 1.55b) / Total Assets 4.99b

(B) -0.35 = Retained Earnings (Balance) -1.75b / Total Assets 4.99b

(D) -0.24 = Book Value of Equity -1.57b / Total Liabilities 6.58b

Total Rating: 0.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 62.00

1. Piotroski 6.0pt

2. FCF Yield 12.15%

3. FCF Margin 12.86%

4. Debt/Equity -3.13

5. Debt/Ebitda 3.18

6. ROIC - WACC (= 33.33)%

7. RoE -46.79%

8. Rev. Trend -21.55%

9. EPS Trend -22.06%

What is the price of BBWI shares?

As of November 24, 2025, the stock is trading at USD 14.85 with a total of 27,383,503 shares traded.
Over the past week, the price has changed by -29.88%, over one month by -44.40%, over three months by -51.69% and over the past year by -57.14%.

Is BBWI a buy, sell or hold?

Bath & Body Works has received a consensus analysts rating of 3.85. Therefore, it is recommended to buy BBWI.

Strong Buy: 7
Buy: 4
Hold: 8
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the BBWI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	24.3	63.3%
Analysts Target Price	24.3	63.3%
ValueRay Target Price	13.4	-9.7%

BBWI Fundamental Data Overview November 23, 2025

Market Cap USD = 3.04b (3.04b USD * 1.0 USD.USD)
P/E Trailing = 4.5975
P/E Forward = 3.9078
P/S = 0.4134
P/EG = 0.4149
Beta = 1.449
Revenue TTM = 7.35b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 1.49b USD
Long Term Debt = 3.89b USD (from longTermDebt, last quarter)
Short Term Debt = 193.0m USD (from shortTermDebt, last quarter)
Debt = 4.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.74b USD (from netDebt column, last quarter)
Enterprise Value = 7.78b USD (3.04b + Debt 4.98b - CCE 236.0m)
Interest Coverage Ratio = 4.34 (Ebit TTM 1.23b / Interest Expense TTM 283.0m)
FCF Yield = 12.15% (FCF TTM 946.0m / Enterprise Value 7.78b)
FCF Margin = 12.86% (FCF TTM 946.0m / Revenue TTM 7.35b)
Net Margin = 9.51% (Net Income TTM 699.0m / Revenue TTM 7.35b)
Gross Margin = 44.13% ((Revenue TTM 7.35b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 41.32%)
Tobins Q-Ratio = 1.56 (Enterprise Value 7.78b / Total Assets 4.99b)
Interest Expense / Debt = 1.37% (Interest Expense 68.0m / Debt 4.98b)
Taxrate = 25.24% (26.0m / 103.0m)
NOPAT = 918.8m (EBIT 1.23b * (1 - 25.24%))
Current Ratio = 1.21 (Total Current Assets 1.88b / Total Current Liabilities 1.55b)
Debt / Equity = -3.13 (negative equity) (Debt 4.98b / totalStockholderEquity, last quarter -1.59b)
Debt / EBITDA = 3.18 (Net Debt 4.74b / EBITDA 1.49b)
Debt / FCF = 5.01 (Net Debt 4.74b / FCF TTM 946.0m)
Total Stockholder Equity = -1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.01% (Net Income 699.0m / Total Assets 4.99b)
RoE = -46.79% (negative equity) (Net Income TTM 699.0m / Total Stockholder Equity -1.49b)
RoCE = 51.29% (EBIT 1.23b / Capital Employed (Equity -1.49b + L.T.Debt 3.89b))
RoIC = 38.40% (NOPAT 918.8m / Invested Capital 2.39b)
WACC = 5.07% (E(3.04b)/V(8.02b) * Re(11.70%) + D(4.98b)/V(8.02b) * Rd(1.37%) * (1-Tc(0.25)))
Discount Rate = 11.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.66%
[DCF Debug] Terminal Value 65.02% ; FCFE base≈824.8m ; Y1≈783.4m ; Y5≈749.7m
Fair Price DCF = 38.35 (DCF Value 7.85b / Shares Outstanding 204.7m; 5y FCF grow -6.55% → 3.0% )
EPS Correlation: -22.06 | EPS CAGR: -45.52% | SUE: -1.68 | # QB: 0
Revenue Correlation: -21.55 | Revenue CAGR: -19.44% | SUE: -1.32 | # QB: 0

Additional Sources for BBWI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle